Search

everythinglearnresearchcommunity

for

Search:↓

Stress may trigger hair loss by affecting immune protection in hair follicles.

The document concludes that injecting platelet-rich plasma can effectively treat androgenetic alopecia, a type of hair loss.

Doctors don't use trichoscopy enough, even though it's good for diagnosing hair problems.

Acute telogen effluvium can be resolved by addressing causes, but chronic telogen effluvium is harder to treat.

PRP therapy significantly improves hair growth and density in men with androgenic alopecia.

Platelet-rich plasma (PRP) is a simple, cost-effective treatment that promotes hair growth and reduces hair loss, with high patient satisfaction.

A patient with zinc depletion improved after zinc supplementation during parenteral nutrition.

Using microneedling with PRP improves skin and hair conditions more than microneedling alone.

Leontopodium alpinum extract may help reduce hair shedding by keeping hair in the growth phase longer.

Trichoscopy helps diagnose and monitor hair and scalp problems without needing many biopsies.

The conclusion is that treatments for Telogen Effluvium exist, but standard treatment guidelines are needed.

A baby was diagnosed with IFAP syndrome due to a new genetic mutation, showing severe skin and developmental issues.

Tiny particles from brain cells help hair grow by targeting a specific hair growth pathway.

QR 678 and QR 678 Neo are safe and promote hair growth, potentially helping chemotherapy-induced hair loss.

Platelet-rich plasma therapy helps increase hair thickness and slow hair loss.

An alternating inflatable head pad reduced pressure ulcers and hair loss in heart surgery patients.

PRP therapy is effective for hair regrowth and improving hair quality with minimal side effects.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

The document concludes that a thorough history, physical exam, and specific tests are crucial for diagnosing and managing hair loss effectively.

Telogen Effluvium is a common, usually reversible hair loss condition, often improved by removing the trigger and possibly treated with various products, though their effectiveness is uncertain.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

Women with lichen planopilaris often have thyroid disease, depression, anxiety, and may respond to treatment with slowed disease progression.

Combining light therapy and microneedling shows promise for treating female hair loss.

Iron deficiency may be related to hair loss, but there's not enough evidence to recommend iron screening or supplements for all hair loss patients.

Iron deficiency is linked to hair loss in CTE patients.

Remove inflamed cysts surgically, avoid topical antibiotics on wounds, treat skin and mouth conditions with specific medications, and address underlying causes of hair loss.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

Hair loss in adult females in Makkah is often linked to iron-deficiency anemia and thyroid issues.

Hair loss is common in IBD patients, and some medications may lower the risk.

Topical oxygen therapy may improve treatments for hair loss, acne, and chronic skin diseases with minimal side effects.